<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Glaucoma and Compliance with Therapy: Strategies for and Barriers to Success - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjVla8vRJ2d@c3ELTeewAAAAU","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success","wgTitle":"Glaucoma and Compliance with Therapy: Strategies for and Barriers to Success","wgCurRevisionId":84972,"wgRevisionId":84972,"wgArticleId":15864,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success",
"wgRelevantArticleId":15864,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,
"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning",
"ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Early and consistent therapy is crucial for the preservation of vision in patients with glaucoma. However, there are many factors that can lower compliance rates and cause non-adherence to treatment plans."/>
<meta name="date" content="2022-08-09"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Glaucoma and Compliance with Therapy: Strategies for and Barriers to Success" href="/w/index.php?title=Special:ExportRDF/Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Glaucoma_and_Compliance_with_Therapy_Strategies_for_and_Barriers_to_Success rootpage-Glaucoma_and_Compliance_with_Therapy_Strategies_for_and_Barriers_to_Success layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Glaucoma+and+Compliance+with+Therapy%3A+Strategies+for+and+Barriers+to+Success" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Glaucoma+and+Compliance+with+Therapy%3A+Strategies+for+and+Barriers+to+Success" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzytj8s7"></button>
					<div class="collapse navbar-collapse hbpzytj8s7" id="hbpzytj8s7">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Glaucoma and Compliance with Therapy: Strategies for and Barriers to Success</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Cody.Blanchard" title="User:Cody.Blanchard">Cody Blanchard, MD</a>,&#8201;<a href="/User:Daniel.B.Moore" title="User:Daniel.B.Moore">Daniel B. Moore, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Daniel.B.Moore" title="User:Daniel.B.Moore">Daniel B. Moore, MD</a>,&#160;<a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Update Pending</b>
</div>
</div>&#160;by <a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a> on August 10, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<p>Glaucoma is the leading cause of blindness worldwide, affecting more than 70 million people.<sup id="cite_ref-parihar1_1-0" class="reference"><a href="#cite_note-parihar1-1">&#91;1&#93;</a></sup> Early and consistent therapy is crucial for the preservation of remaining vision in patients with the disease. However, there are many factors that can lower compliance rates and cause non-adherence to treatment plans, which has reported rates of 30-80%.<sup id="cite_ref-schwartz2_2-0" class="reference"><a href="#cite_note-schwartz2-2">&#91;2&#93;</a></sup> <sup id="cite_ref-olthoff3_3-0" class="reference"><a href="#cite_note-olthoff3-3">&#91;3&#93;</a></sup> 
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Beliefs_and_Lack_of_Knowledge_about_Glaucoma_and_Treatment_Methods"><span class="tocnumber">1</span> <span class="toctext">Beliefs and Lack of Knowledge about Glaucoma and Treatment Methods</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Difficulty_with_Obtaining_and_Administering_Eye_Drops"><span class="tocnumber">2</span> <span class="toctext">Difficulty with Obtaining and Administering Eye Drops</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Strategies_and_Interventions_to_Increase_Adherence"><span class="tocnumber">3</span> <span class="toctext">Strategies and Interventions to Increase Adherence</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Conclusion"><span class="tocnumber">4</span> <span class="toctext">Conclusion</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#References"><span class="tocnumber">5</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Beliefs_and_Lack_of_Knowledge_about_Glaucoma_and_Treatment_Methods">Beliefs and Lack of Knowledge about Glaucoma and Treatment Methods</span></h1>
<p>Many studies have found that patients diagnosed with glaucoma may not truly understand the potential for severe, vision-threatening consequences with inadequately treated disease, and the potential benefits of adherence to the treatment plan developed by the ophthalmologist.<sup id="cite_ref-friedman4_4-0" class="reference"><a href="#cite_note-friedman4-4">&#91;4&#93;</a></sup> <sup id="cite_ref-lacey5_5-0" class="reference"><a href="#cite_note-lacey5-5">&#91;5&#93;</a></sup> <sup id="cite_ref-tsai6_6-0" class="reference"><a href="#cite_note-tsai6-6">&#91;6&#93;</a></sup> <sup id="cite_ref-sleath7_7-0" class="reference"><a href="#cite_note-sleath7-7">&#91;7&#93;</a></sup> <sup id="cite_ref-subathra8_8-0" class="reference"><a href="#cite_note-subathra8-8">&#91;8&#93;</a></sup> <sup id="cite_ref-kanu9_9-0" class="reference"><a href="#cite_note-kanu9-9">&#91;9&#93;</a></sup> As a largely asymptomatic disease, it may be difficult for patients to appreciate disease progression with non-adherence or conversely preservation with appropriate use of therapy.  This leads to a lack of trust and faith in the treating physician, which can increase the likelihood that a patient will be non-adherent to their medications.<sup id="cite_ref-kanu9_9-1" class="reference"><a href="#cite_note-kanu9-9">&#91;9&#93;</a></sup><sup id="cite_ref-stryker10_10-0" class="reference"><a href="#cite_note-stryker10-10">&#91;10&#93;</a></sup> <sup id="cite_ref-lunnela11_11-0" class="reference"><a href="#cite_note-lunnela11-11">&#91;11&#93;</a></sup> <sup id="cite_ref-killeen12_12-0" class="reference"><a href="#cite_note-killeen12-12">&#91;12&#93;</a></sup> <sup id="cite_ref-muir13_13-0" class="reference"><a href="#cite_note-muir13-13">&#91;13&#93;</a></sup> 
</p><p>The low level of knowledge by the general public about the manifestations of glaucoma and the threat of vision loss that comes along with the disease also plays an important role in the low rates of adherence that is seen among these patients.<sup id="cite_ref-meiergibbons14_14-0" class="reference"><a href="#cite_note-meiergibbons14-14">&#91;14&#93;</a></sup> This also can be attributed to poor health literacy, which is seen among patients dealing with a wide array of conditions, but especially glaucoma patients.<sup id="cite_ref-muir15_15-0" class="reference"><a href="#cite_note-muir15-15">&#91;15&#93;</a></sup> <sup id="cite_ref-muir16_16-0" class="reference"><a href="#cite_note-muir16-16">&#91;16&#93;</a></sup> <sup id="cite_ref-juzych17_17-0" class="reference"><a href="#cite_note-juzych17-17">&#91;17&#93;</a></sup> <sup id="cite_ref-tsai18_18-0" class="reference"><a href="#cite_note-tsai18-18">&#91;18&#93;</a></sup> 
</p>
<h1><span class="mw-headline" id="Difficulty_with_Obtaining_and_Administering_Eye_Drops">Difficulty with Obtaining and Administering Eye Drops</span></h1>
<p>Another important factor that affects adherence rates is the difficulty that is reported by patients when trying to obtain glaucoma medications. Cost is a significant barrier to accessing care for many patients, and this has been seen in multiple settings and patient populations.<sup id="cite_ref-friedman4_4-1" class="reference"><a href="#cite_note-friedman4-4">&#91;4&#93;</a></sup> <sup id="cite_ref-subathra8_8-1" class="reference"><a href="#cite_note-subathra8-8">&#91;8&#93;</a></sup> <sup id="cite_ref-killeen12_12-1" class="reference"><a href="#cite_note-killeen12-12">&#91;12&#93;</a></sup> <sup id="cite_ref-meiergibbons14_14-1" class="reference"><a href="#cite_note-meiergibbons14-14">&#91;14&#93;</a></sup><sup id="cite_ref-blumberg19_19-0" class="reference"><a href="#cite_note-blumberg19-19">&#91;19&#93;</a></sup> <sup id="cite_ref-newmancasey20_20-0" class="reference"><a href="#cite_note-newmancasey20-20">&#91;20&#93;</a></sup> Even when patients are able to obtain their medications, many experience difficulties with administering drops. This can be attributed to difficulties reading the print on the bottle,<sup id="cite_ref-newmancasey20_20-1" class="reference"><a href="#cite_note-newmancasey20-20">&#91;20&#93;</a></sup><sup id="cite_ref-sleath21_21-0" class="reference"><a href="#cite_note-sleath21-21">&#91;21&#93;</a></sup> forgetfulness,<sup id="cite_ref-newmancasey20_20-2" class="reference"><a href="#cite_note-newmancasey20-20">&#91;20&#93;</a></sup> the effects of other chronic conditions increasing the difficulty of managing glaucoma,<sup id="cite_ref-kanu9_9-2" class="reference"><a href="#cite_note-kanu9-9">&#91;9&#93;</a></sup><sup id="cite_ref-stringham22_22-0" class="reference"><a href="#cite_note-stringham22-22">&#91;22&#93;</a></sup> <sup id="cite_ref-jones23_23-0" class="reference"><a href="#cite_note-jones23-23">&#91;23&#93;</a></sup> <sup id="cite_ref-asefzadeh24_24-0" class="reference"><a href="#cite_note-asefzadeh24-24">&#91;24&#93;</a></sup> <sup id="cite_ref-lee25_25-0" class="reference"><a href="#cite_note-lee25-25">&#91;25&#93;</a></sup> and difficulties with applying the correct amount of force and having adequate visual acuity and dexterity to only get the number of drops desired,<sup id="cite_ref-moore26_26-0" class="reference"><a href="#cite_note-moore26-26">&#91;26&#93;</a></sup> <sup id="cite_ref-moore27_27-0" class="reference"><a href="#cite_note-moore27-27">&#91;27&#93;</a></sup> <sup id="cite_ref-hennessy28_28-0" class="reference"><a href="#cite_note-hennessy28-28">&#91;28&#93;</a></sup> among other factors. 
</p>
<h1><span class="mw-headline" id="Strategies_and_Interventions_to_Increase_Adherence">Strategies and Interventions to Increase Adherence</span></h1>
<p>There have been many studies into interventions and strategies that have been shown to improve adherence to a glaucoma treatment plan. Most of these work to specifically address barriers discussed above. For example, incorporating discussions of beliefs about glaucoma and treatment methods will help to address misinterpretations of the disease and also help to build trust in the patient-physician relationship, especially when patient-centered communication is used, leaving the patient feeling like an active participant in their own healthcare.<sup id="cite_ref-newmancasey20_20-3" class="reference"><a href="#cite_note-newmancasey20-20">&#91;20&#93;</a></sup><sup id="cite_ref-hahn29_29-0" class="reference"><a href="#cite_note-hahn29-29">&#91;29&#93;</a></sup> <sup id="cite_ref-mansukani30_30-0" class="reference"><a href="#cite_note-mansukani30-30">&#91;30&#93;</a></sup> <sup id="cite_ref-mcDonald31_31-0" class="reference"><a href="#cite_note-mcDonald31-31">&#91;31&#93;</a></sup> 
</p><p>Another method to improve adherence involves improving health literacy as a whole in this patient population, especially among those newly diagnosed or those struggling with non-compliance. This has been completed using videos discussing glaucoma, including the anatomy of the eye and examples of what vision loss in glaucoma looks like, and also the potential treatment options available and instructions for their use.<sup id="cite_ref-muir16_16-1" class="reference"><a href="#cite_note-muir16-16">&#91;16&#93;</a></sup><sup id="cite_ref-okeke32_32-0" class="reference"><a href="#cite_note-okeke32-32">&#91;32&#93;</a></sup> <sup id="cite_ref-davis33_33-0" class="reference"><a href="#cite_note-davis33-33">&#91;33&#93;</a></sup> <sup id="cite_ref-schneider34_34-0" class="reference"><a href="#cite_note-schneider34-34">&#91;34&#93;</a></sup> 
</p><p>Difficulties with medication bottles, whether reading the print or just forgetting to use them, are common and multiple interventions have been successful in combatting this. Some options include personalized mail and phone call reminders of appointments and medication administration times.<sup id="cite_ref-okeke32_32-1" class="reference"><a href="#cite_note-okeke32-32">&#91;32&#93;</a></sup><sup id="cite_ref-pizzi35_35-0" class="reference"><a href="#cite_note-pizzi35-35">&#91;35&#93;</a></sup> One important development of note in this area involves the development of the EyePhone© App, which provides notifications and reminders of current medical treatment, and it has been found to significantly increase glaucoma treatment adherence and improve quality of life.<sup id="cite_ref-leshno36_36-0" class="reference"><a href="#cite_note-leshno36-36">&#91;36&#93;</a></sup> 
</p><p>Another issue that can be addressed through upcoming technological interventions is the struggle of administering only one drop at a time. A contributing factor is the significant variability that has been noted between bottles in terms of the amount of force needed to produce one drop.<sup id="cite_ref-moore26_26-1" class="reference"><a href="#cite_note-moore26-26">&#91;26&#93;</a></sup> This can lead to multiple drops being used, and thus early exhaustion of drop supply, which has been found to be fairly common in a pilot study of glaucoma patients.<sup id="cite_ref-moore27_27-1" class="reference"><a href="#cite_note-moore27-27">&#91;27&#93;</a></sup> A team from University of California – San Diego is working to establish the use of a smart electronic eyedrop bottle that measures the number of single- and multiple-drop deliveries and provides a potential solution for remote glaucoma eyedrop monitoring.<sup id="cite_ref-aguilarrivera37_37-0" class="reference"><a href="#cite_note-aguilarrivera37-37">&#91;37&#93;</a></sup> Another promising development in this space is the use of a nose-pivoted drop delivery device, which was found to improve eye drop delivery success, reduce bottle tip contact, and decrease the number of eye drops wasted, leaving it strongly preferred by patients over a traditional drop delivery system.<sup id="cite_ref-sanchez38_38-0" class="reference"><a href="#cite_note-sanchez38-38">&#91;38&#93;</a></sup>
</p><p>Lastly, it is important to mention a shift in treatment protocol for glaucoma away from the medication-first model to the early and repeated use of selective laser trabeculoplasty (SLT). SLT involves the use of a Nd:YAG laser to improve drainage through the trabecular meshwork, thus lowering intraocular pressure (IOP). In a recent systematic review, SLT was proven to be effective at lowering IOP with high success rates, even after a single treatment, and has the added benefit of being independent of a patient’s capacity to remain compliant with a treatment plan.<sup id="cite_ref-totebergharms39_39-0" class="reference"><a href="#cite_note-totebergharms39-39">&#91;39&#93;</a></sup> The Clarifying the Optimal Application of SLT Therapy (COAST) Trial is being initiated to determine the utility of low-energy SLT conducted annually as primary treatment for mild to moderate open angle glaucoma.<sup id="cite_ref-realini40_40-0" class="reference"><a href="#cite_note-realini40-40">&#91;40&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="Conclusion">Conclusion</span></h1>
<p>In summary, treatment non-adherence is frequently seen among glaucoma patients, and is associated with lack of understanding of the threat to vision from glaucoma, mistrust of the treatment plan and the potential benefits of adhering to it, and difficulty affording and using drops. There are many interventions to address these barriers, including “smart” eyedrop bottles to provide remote monitoring of adherence and proper usage of drops, smartphone apps to give personalized reminders of when to use medication, and educational videos to improve health literacy and knowledge about glaucoma and dispel common misconceptions about the disease.  Laser treatments are increasingly being advocated as an alternative first line therapy where available, and future therapeutics will likely also consider the difficulties and barriers to frequent eyedrop administration.
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-parihar1-1"><span class="mw-cite-backlink"><a href="#cite_ref-parihar1_1-0">↑</a></span> <span class="reference-text">Parihar JK. Glaucoma: The 'Black hole' of irreversible blindness. Med J Armed Forces India. 2016;72(1):3-4.</span>
</li>
<li id="cite_note-schwartz2-2"><span class="mw-cite-backlink"><a href="#cite_ref-schwartz2_2-0">↑</a></span> <span class="reference-text">Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53 Suppl1:S57-68.</span>
</li>
<li id="cite_note-olthoff3-3"><span class="mw-cite-backlink"><a href="#cite_ref-olthoff3_3-0">↑</a></span> <span class="reference-text">Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953-961.</span>
</li>
<li id="cite_note-friedman4-4"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-friedman4_4-0">4.0</a></sup> <sup><a href="#cite_ref-friedman4_4-1">4.1</a></sup></span> <span class="reference-text">friedman ds, hahn sr, gelb l, et al. doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the glaucoma adherence and persistency study. ophthalmology. 2008;115(8):1320-1327, 1327.e1321-1323.</span>
</li>
<li id="cite_note-lacey5-5"><span class="mw-cite-backlink"><a href="#cite_ref-lacey5_5-0">↑</a></span> <span class="reference-text">lacey j, cate h, broadway dc. barriers to adherence with glaucoma medications: a qualitative research study. eye (lond). 2009;23(4):924-932.</span>
</li>
<li id="cite_note-tsai6-6"><span class="mw-cite-backlink"><a href="#cite_ref-tsai6_6-0">↑</a></span> <span class="reference-text">tsai jc, mcclure ca, ramos se, schlundt dg, pichert jw. compliance barriers in glaucoma: a systematic classification. j glaucoma. 2003;12(5):393-398.</span>
</li>
<li id="cite_note-sleath7-7"><span class="mw-cite-backlink"><a href="#cite_ref-sleath7_7-0">↑</a></span> <span class="reference-text">sleath b, blalock sj, robin a, et al. development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. eye (lond). 2010;24(4):624-631.</span>
</li>
<li id="cite_note-subathra8-8"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-subathra8_8-0">8.0</a></sup> <sup><a href="#cite_ref-subathra8_8-1">8.1</a></sup></span> <span class="reference-text">subathra gn, rajendrababu sr, senthilkumar va, mani i, udayakumar b. impact of covid-19 on follow-up and medication adherence in patients with glaucoma in a tertiary eye care centre in south india. indian j ophthalmol. 2021;69(5):1264-1270.</span>
</li>
<li id="cite_note-kanu9-9"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-kanu9_9-0">9.0</a></sup> <sup><a href="#cite_ref-kanu9_9-1">9.1</a></sup> <sup><a href="#cite_ref-kanu9_9-2">9.2</a></sup></span> <span class="reference-text">kanu ln, jang i, oh dj, et al. glaucoma care of prison inmates at an academic hospital. jama ophthalmol. 2020;138(4):358-364.</span>
</li>
<li id="cite_note-stryker10-10"><span class="mw-cite-backlink"><a href="#cite_ref-stryker10_10-0">↑</a></span> <span class="reference-text">Stryker JE, Beck AD, Primo SA, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19(1):66-72.</span>
</li>
<li id="cite_note-lunnela11-11"><span class="mw-cite-backlink"><a href="#cite_ref-lunnela11_11-0">↑</a></span> <span class="reference-text">Lunnela J, Kääriäinen M, Kyngäs H. The views of compliant glaucoma patients on counselling and social support. Scand J Caring Sci. 2010;24(3):490-498.</span>
</li>
<li id="cite_note-killeen12-12"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-killeen12_12-0">12.0</a></sup> <sup><a href="#cite_ref-killeen12_12-1">12.1</a></sup></span> <span class="reference-text">Killeen OJ, Pillai MR, Udayakumar B, et al. Understanding Barriers to Glaucoma Treatment Adherence among Participants in South India. Ophthalmic Epidemiol. 2020;27(3):200-208.</span>
</li>
<li id="cite_note-muir13-13"><span class="mw-cite-backlink"><a href="#cite_ref-muir13_13-0">↑</a></span> <span class="reference-text">Muir KW, Alder B, Thomas A, Crowell SS, Stinnett SS, Lee PP. Trust in the provider and glaucoma-related blindness. ISRN Ophthalmol. 2012;2012:393917.</span>
</li>
<li id="cite_note-meiergibbons14-14"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-meiergibbons14_14-0">14.0</a></sup> <sup><a href="#cite_ref-meiergibbons14_14-1">14.1</a></sup></span> <span class="reference-text">Meier-Gibbons F, Töteberg-Harms M. Influence of Cost of Care and Adherence in Glaucoma Management: An Update. J Ophthalmol. 2020;2020:5901537.</span>
</li>
<li id="cite_note-muir15-15"><span class="mw-cite-backlink"><a href="#cite_ref-muir15_15-0">↑</a></span> <span class="reference-text">Muir KW, Santiago-Turla C, Stinnett SS, et al. Health literacy and adherence to glaucoma therapy. Am J Ophthalmol. 2006;142(2):223-226.</span>
</li>
<li id="cite_note-muir16-16"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-muir16_16-0">16.0</a></sup> <sup><a href="#cite_ref-muir16_16-1">16.1</a></sup></span> <span class="reference-text">Muir KW, Ventura A, Stinnett SS, Enfiedjian A, Allingham RR, Lee PP. The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Patient Educ Couns. 2012;87(2):160-164.</span>
</li>
<li id="cite_note-juzych17-17"><span class="mw-cite-backlink"><a href="#cite_ref-juzych17_17-0">↑</a></span> <span class="reference-text">Juzych MS, Randhawa S, Shukairy A, Kaushal P, Gupta A, Shalauta N. Functional health literacy in patients with glaucoma in urban settings. Arch Ophthalmol. 2008;126(5):718-724.</span>
</li>
<li id="cite_note-tsai18-18"><span class="mw-cite-backlink"><a href="#cite_ref-tsai18_18-0">↑</a></span> <span class="reference-text">Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11 Suppl):S30-36.</span>
</li>
<li id="cite_note-blumberg19-19"><span class="mw-cite-backlink"><a href="#cite_ref-blumberg19_19-0">↑</a></span> <span class="reference-text">Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, De Moraes CG. Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D. JAMA Ophthalmol. 2015;133(9):985-996.</span>
</li>
<li id="cite_note-newmancasey20-20"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-newmancasey20_20-0">20.0</a></sup> <sup><a href="#cite_ref-newmancasey20_20-1">20.1</a></sup> <sup><a href="#cite_ref-newmancasey20_20-2">20.2</a></sup> <sup><a href="#cite_ref-newmancasey20_20-3">20.3</a></sup></span> <span class="reference-text">Newman-Casey PA, Robin AL, Blachley T, et al. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey. Ophthalmology. 2015;122(7):1308-1316.</span>
</li>
<li id="cite_note-sleath21-21"><span class="mw-cite-backlink"><a href="#cite_ref-sleath21_21-0">↑</a></span> <span class="reference-text">Sleath B, Ballinger R, Covert D, Robin AL, Byrd JE, Tudor G. Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatients. Am J Geriatr Pharmacother. 2009;7(2):67-73.</span>
</li>
<li id="cite_note-stringham22-22"><span class="mw-cite-backlink"><a href="#cite_ref-stringham22_22-0">↑</a></span> <span class="reference-text">Stringham J, Ashkenazy N, Galor A, Wellik SR. Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders. Eye Contact Lens. 2018;44(1):50-54.</span>
</li>
<li id="cite_note-jones23-23"><span class="mw-cite-backlink"><a href="#cite_ref-jones23_23-0">↑</a></span> <span class="reference-text">Jones JP, Fong DS, Fang EN, Mesirov CA, Patel V. Characterization of Glaucoma Medication Adherence in Kaiser Permanente Southern California. J Glaucoma. 2016;25(1):22-26.</span>
</li>
<li id="cite_note-asefzadeh24-24"><span class="mw-cite-backlink"><a href="#cite_ref-asefzadeh24_24-0">↑</a></span> <span class="reference-text">Asefzadeh B, Rett D, Pogoda TK, Selvin G, Cavallerano A. Glaucoma medication adherence in veterans and influence of coexisting chronic disease. J Glaucoma. 2014;23(4):240-245.</span>
</li>
<li id="cite_note-lee25-25"><span class="mw-cite-backlink"><a href="#cite_ref-lee25_25-0">↑</a></span> <span class="reference-text">Lee BW, Murakami Y, Duncan MT, et al. Patient-related and system-related barriers to glaucoma follow-up in a county hospital population. Invest Ophthalmol Vis Sci. 2013;54(10):6542-6548.</span>
</li>
<li id="cite_note-moore26-26"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-moore26_26-0">26.0</a></sup> <sup><a href="#cite_ref-moore26_26-1">26.1</a></sup></span> <span class="reference-text">Moore DB, Hammer JD, Akhtari R, Beck J, Sanders S, Kryscio RJ. Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles. J Glaucoma. 2016;25(9):780-784.</span>
</li>
<li id="cite_note-moore27-27"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-moore27_27-0">27.0</a></sup> <sup><a href="#cite_ref-moore27_27-1">27.1</a></sup></span> <span class="reference-text">Moore DB, Walton C, Moeller KL, Slabaugh MA, Mudumbai RC, Chen PP. Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey. BMC Ophthalmol. 2014;14:79.</span>
</li>
<li id="cite_note-hennessy28-28"><span class="mw-cite-backlink"><a href="#cite_ref-hennessy28_28-0">↑</a></span> <span class="reference-text">Hennessy AL, Katz J, Covert D, et al. A video study of drop instillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol. 2011;152(6):982-988.</span>
</li>
<li id="cite_note-hahn29-29"><span class="mw-cite-backlink"><a href="#cite_ref-hahn29_29-0">↑</a></span> <span class="reference-text">Hahn SR. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology. 2009;116(11 Suppl):S37-42.</span>
</li>
<li id="cite_note-mansukani30-30"><span class="mw-cite-backlink"><a href="#cite_ref-mansukani30_30-0">↑</a></span> <span class="reference-text">Mansukani SS. Improving adherence to drug-treatment regimens for glaucoma. Manag Care. 2002;11(11 Suppl):49-53.</span>
</li>
<li id="cite_note-mcDonald31-31"><span class="mw-cite-backlink"><a href="#cite_ref-mcDonald31_31-0">↑</a></span> <span class="reference-text">McDonald JE, Dickinson JK. A Novel Approach to Helping People with Glaucoma Use Their Drops Routinely. Optom Vis Sci. 2019;96(5):331-334.</span>
</li>
<li id="cite_note-okeke32-32"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-okeke32_32-0">32.0</a></sup> <sup><a href="#cite_ref-okeke32_32-1">32.1</a></sup></span> <span class="reference-text">Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116(12):2286-2293.</span>
</li>
<li id="cite_note-davis33-33"><span class="mw-cite-backlink"><a href="#cite_ref-davis33_33-0">↑</a></span> <span class="reference-text">Davis SA, Carpenter DM, Blalock SJ, et al. Glaucoma Patient Preferences for Video Education on Eye Drop Technique. Optom Vis Sci. 2019;96(5):325-330.</span>
</li>
<li id="cite_note-schneider34-34"><span class="mw-cite-backlink"><a href="#cite_ref-schneider34_34-0">↑</a></span> <span class="reference-text">Schneider KJ, Hollenhorst CN, Valicevic AN, et al. Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy. Ophthalmol Glaucoma. 2021;4(1):42-50.</span>
</li>
<li id="cite_note-pizzi35-35"><span class="mw-cite-backlink"><a href="#cite_ref-pizzi35_35-0">↑</a></span> <span class="reference-text">Pizzi LT, Tran J, Shafa A, et al. Effectiveness and Cost of a Personalized Reminder Intervention to Improve Adherence to Glaucoma Care. Appl Health Econ Health Policy. 2016;14(2):229-240.</span>
</li>
<li id="cite_note-leshno36-36"><span class="mw-cite-backlink"><a href="#cite_ref-leshno36_36-0">↑</a></span> <span class="reference-text">Leshno A, Gaton D, Singer R, et al. A novel EyePhone(c) App for improving adherence to glaucoma therapy. Graefes Arch Clin Exp Ophthalmol. 2021;259(5):1253-1262.</span>
</li>
<li id="cite_note-aguilarrivera37-37"><span class="mw-cite-backlink"><a href="#cite_ref-aguilarrivera37_37-0">↑</a></span> <span class="reference-text">Aguilar-Rivera M, Erudaitius DT, Wu VM, et al. Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence. Sensors (Basel). 2020;20(9).</span>
</li>
<li id="cite_note-sanchez38-38"><span class="mw-cite-backlink"><a href="#cite_ref-sanchez38_38-0">↑</a></span> <span class="reference-text">Sanchez FG, Mansberger SL, Kung Y, et al. Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction. Ophthalmol Glaucoma. 2021.</span>
</li>
<li id="cite_note-totebergharms39-39"><span class="mw-cite-backlink"><a href="#cite_ref-totebergharms39_39-0">↑</a></span> <span class="reference-text">Toteberg-Harms M, Meier-Gibbons F. Is laser trabeculoplasty the new star in glaucoma treatment? Curr Opin Ophthalmol. 2021;32(2):141-147.</span>
</li>
<li id="cite_note-realini40-40"><span class="mw-cite-backlink"><a href="#cite_ref-realini40_40-0">↑</a></span> <span class="reference-text">Realini T, Gazzard G, Latina M, Kass M. Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial. J Glaucoma. 2021;30(7):545-551.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035151
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.001 seconds
CPU time usage: 0.184 seconds
Real time usage: 0.813 seconds
Preprocessor visited node count: 886/1000000
Post‐expand include size: 5998/2097152 bytes
Template argument size: 1824/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 19538/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  369.286      1 Template:Article
100.00%  369.286      1 -total
 86.41%  319.103      4 Template:Infobox_section
 35.82%  132.280      6 Template:UserLookup
  9.80%   36.183      1 Template:Get_active_contest
  8.46%   31.242      1 Template:Review_expired
  0.25%    0.936      1 Template:Infobox_begin
  0.25%    0.910      1 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;oldid=84972">https://eyewiki.org/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;oldid=84972</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzytjryp">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;oldid=84972" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Glaucoma_and_Compliance_with_Therapy:_Strategies_for_and_Barriers_to_Success&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on September 12, 2022, at 08:28.</div>
					<div>This page has been accessed 2,618 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.001},"limitreport":{"cputime":"0.184","walltime":"0.813","ppvisitednodes":{"value":886,"limit":1000000},"postexpandincludesize":{"value":5998,"limit":2097152},"templateargumentsize":{"value":1824,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":19538,"limit":5000000},"timingprofile":["100.00%  369.286      1 Template:Article","100.00%  369.286      1 -total"," 86.41%  319.103      4 Template:Infobox_section"," 35.82%  132.280      6 Template:UserLookup","  9.80%   36.183      1 Template:Get_active_contest","  8.46%   31.242      1 Template:Review_expired","  0.25%    0.936      1 Template:Infobox_begin","  0.25%    0.910      1 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035151","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":1264});});</script></body>
</html>